Yearly Archives: 2013

­

Biocon and Quark Pharmaceuticals Collaborate to Develop Novel siRNA based Therapeutics

December 18th, 2013|

Bangalore, India, and Fremont, CA, December 18, 2013  

Biocon Ltd, Asia’s premier biotechnology company, and Quark Pharmaceuticals, Inc,. a world leader in the discovery and development of siRNA-based therapeutics, announced today that they have entered into a Licensing  & Collaboration agreement for the development of  a range of siRNA ( small interfering RNA)  based novel therapeutics.

This […]